Design of an ongoing phase I/II open-label, dose-escalation trial using the oral chelator deferasirox to treat iron overload in HFE-Related hereditary hemochromatosis (HH)

Authors
Publication date
1 January 2007
Publisher

Abstract

no abstract availabl

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio istituzionale della ricerca - Università di Modena e Reggio Emilia

    redirect
    oaioai:iris.unimore.it:11380/6056...
    Last time updated on 07/08/2017